Skip to main content
Erschienen in: Clinical Rheumatology 10/2018

09.07.2018 | Original Article

Clinical characteristics and risk factors of infections in patients with systemic lupus erythematosus

verfasst von: Chengcheng Hou, Ou Jin, Xi Zhang

Erschienen in: Clinical Rheumatology | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Abstract

To investigate the clinical characteristics of infection in SLE patients and analyze the risk factors of infection. A retrospective analysis method was used and the data were collected from 173 case times of 142 hospitalized patients. We found the incidence rate of infections in SLE was 50.7%. The most common infection sites were lungs, followed by upper respiratory tracts and urinary tracts. The most common pathogens were bacteria, followed by fungi. The infection-associated risk factors were duration of hospitalization, lupus activity state, the use of high-dose corticosteroids and immunosuppressive agents, the low serum level of complements 3 and 4 (C3 and C4), fever, the high level of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), the abnormality of white blood cell (< 4 × 109/L or > 10 × 109/L), and the low level of albumin (P < 0.05 or P < 0.001). The independent risk factors for SLE patients with infection consist of the abnormality of white blood cells, the high level of CRP, the low serum level of C4, and longtime hospitalization. Attention should be paid to the risk factors of infection, and treatment to enhance immunity should be carried out to reduce the chance of infection.
Literatur
1.
Zurück zum Zitat Dubula T, Mody GM (2015) Spectrum of infections and outcome among hospitalized South Africans with systemic lupus erythematosus. Clin Rheumatol 34(3):479–488CrossRefPubMed Dubula T, Mody GM (2015) Spectrum of infections and outcome among hospitalized South Africans with systemic lupus erythematosus. Clin Rheumatol 34(3):479–488CrossRefPubMed
2.
Zurück zum Zitat Wu L, Wang X, Chen F, Lv X, Sun W, Guo Y, Hou H, Ji H, Wei W, Gong L (2017) T cell subsets and immunoglobulin G levels are associated with the infection status of systemic lupus erythematosus patients. Braz J Med Biol Res 51(2):e4547PubMedPubMedCentral Wu L, Wang X, Chen F, Lv X, Sun W, Guo Y, Hou H, Ji H, Wei W, Gong L (2017) T cell subsets and immunoglobulin G levels are associated with the infection status of systemic lupus erythematosus patients. Braz J Med Biol Res 51(2):e4547PubMedPubMedCentral
3.
Zurück zum Zitat Jung JY, Suh CH (2017) Infection in systemic lupus erythematosus, similarities, and differences with lupus flare. Korean J Intern Med 32(3):429–438CrossRefPubMedPubMedCentral Jung JY, Suh CH (2017) Infection in systemic lupus erythematosus, similarities, and differences with lupus flare. Korean J Intern Med 32(3):429–438CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Wang KC, Liu PH, Yu KH, Weng YM, Ng CJ, Chiu TF, Chen SY (2017) Is initial C-reactive protein level associated with corticosteroid use in lupus erythematosus patients during a bacterial infection episode? Immunol Lett 185:84–89CrossRefPubMed Wang KC, Liu PH, Yu KH, Weng YM, Ng CJ, Chiu TF, Chen SY (2017) Is initial C-reactive protein level associated with corticosteroid use in lupus erythematosus patients during a bacterial infection episode? Immunol Lett 185:84–89CrossRefPubMed
5.
Zurück zum Zitat Lin H, Wei JC, Tan CY, Liu YY, Li YH, Li FX (2012) Survival analysis of late-onset systemic lupus erythematosus: a cohort study in China. Clin Rheumatol 31:1683–1689CrossRefPubMed Lin H, Wei JC, Tan CY, Liu YY, Li YH, Li FX (2012) Survival analysis of late-onset systemic lupus erythematosus: a cohort study in China. Clin Rheumatol 31:1683–1689CrossRefPubMed
6.
Zurück zum Zitat Chen CH, Tai SB, Chen HC, Yang DH, Peng MY, Lin YF (2015) Analysis of erythrocyte C4d to complement receptor 1 ratio: use in distinguishing between infection and flare-up in febrile patients with systemic lupus erythematosus. Biomed Res Int 2015:939783PubMedPubMedCentral Chen CH, Tai SB, Chen HC, Yang DH, Peng MY, Lin YF (2015) Analysis of erythrocyte C4d to complement receptor 1 ratio: use in distinguishing between infection and flare-up in febrile patients with systemic lupus erythematosus. Biomed Res Int 2015:939783PubMedPubMedCentral
7.
Zurück zum Zitat Hahn BH, Mcmahon MA, Wilkinson A (2012) American College of Rheumatology guidelines for guidelines for screening, treatment, and management of lupus nephritis [J]. Arthritis Care Res 64(6):797–808CrossRef Hahn BH, Mcmahon MA, Wilkinson A (2012) American College of Rheumatology guidelines for guidelines for screening, treatment, and management of lupus nephritis [J]. Arthritis Care Res 64(6):797–808CrossRef
8.
Zurück zum Zitat Badr G, Sayed A, Abdel-Maksoud MA, Mohamed AO, El-Amir A, Abdel-Ghaffar FA, Al-Quraishy S, Mahmoud MH (2015) Infection of female BWF1 lupus mice with malaria parasite attenuates B cell autoreactivity by modulating the CXCL12/CXCR4 Axis and its downstream signals PI3K/AKT, NFκB and ERK. PLoS One 10(4):e0125340CrossRefPubMedPubMedCentral Badr G, Sayed A, Abdel-Maksoud MA, Mohamed AO, El-Amir A, Abdel-Ghaffar FA, Al-Quraishy S, Mahmoud MH (2015) Infection of female BWF1 lupus mice with malaria parasite attenuates B cell autoreactivity by modulating the CXCL12/CXCR4 Axis and its downstream signals PI3K/AKT, NFκB and ERK. PLoS One 10(4):e0125340CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Wu SA, Yeh KW, Lee WI, Yao TC, Kuo ML, Huang B, Huang JL (2013) Impaired phagocytosis and susceptibility to infection in pediatric-onset systemic lupus erythematosus. Lupus 22(3):279–288CrossRefPubMed Wu SA, Yeh KW, Lee WI, Yao TC, Kuo ML, Huang B, Huang JL (2013) Impaired phagocytosis and susceptibility to infection in pediatric-onset systemic lupus erythematosus. Lupus 22(3):279–288CrossRefPubMed
10.
Zurück zum Zitat Cervera R, Khamashta MA, Font J (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore) 82:299–308CrossRef Cervera R, Khamashta MA, Font J (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore) 82:299–308CrossRef
11.
Zurück zum Zitat Yurkovich M, Vostretsova K, Chen W, Avina-Zubieta JA (2014) Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res 66:608–616CrossRef Yurkovich M, Vostretsova K, Chen W, Avina-Zubieta JA (2014) Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res 66:608–616CrossRef
12.
Zurück zum Zitat Tektonidou MG, Wang Z, Dasgupta A, Ward MM (2015) Burden of serious infections in adults with systemic lupus erythematosus: a National Population-Based Study, 1996–2011. Arthritis Care Res 67(8):1078–1085CrossRef Tektonidou MG, Wang Z, Dasgupta A, Ward MM (2015) Burden of serious infections in adults with systemic lupus erythematosus: a National Population-Based Study, 1996–2011. Arthritis Care Res 67(8):1078–1085CrossRef
13.
Zurück zum Zitat Han BK, Bhatia R, Traisak P (2013) Clinical presentations and outcomes of systemic lupus erythematosus patients with infection admitted to the intensive care unit. Lupus 22(7):690–696CrossRefPubMed Han BK, Bhatia R, Traisak P (2013) Clinical presentations and outcomes of systemic lupus erythematosus patients with infection admitted to the intensive care unit. Lupus 22(7):690–696CrossRefPubMed
14.
Zurück zum Zitat Ekwom PE (2013) Systemic lupus erythematosus (SLE) at the Kenyatta National Hospital. Clin Rheumatol 32(8):1215–1217CrossRefPubMed Ekwom PE (2013) Systemic lupus erythematosus (SLE) at the Kenyatta National Hospital. Clin Rheumatol 32(8):1215–1217CrossRefPubMed
15.
Zurück zum Zitat Jeong SJ, Choi H, Lee HS, Han SH, Chin BS, Baek JH, Kim CO, Choi JY, Song YG, Kim JM (2009) Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus. Scand J Infect Dis 41(4):268–274CrossRefPubMed Jeong SJ, Choi H, Lee HS, Han SH, Chin BS, Baek JH, Kim CO, Choi JY, Song YG, Kim JM (2009) Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus. Scand J Infect Dis 41(4):268–274CrossRefPubMed
16.
Zurück zum Zitat Chen D, Xie J, Chen H, Yang Y, Zhan Z, Liang L, Yang X (2016) Infection in southern Chinese patients with systemic lupus erythematosus: spectrum, drug resistance, outcomes, and risk factors. J Rheumatol 43(9):1650–1656CrossRefPubMed Chen D, Xie J, Chen H, Yang Y, Zhan Z, Liang L, Yang X (2016) Infection in southern Chinese patients with systemic lupus erythematosus: spectrum, drug resistance, outcomes, and risk factors. J Rheumatol 43(9):1650–1656CrossRefPubMed
17.
Zurück zum Zitat Goldblatt F, Chambers S, Rahman A, Isenberg DA (2009) Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus 18:682–689CrossRefPubMed Goldblatt F, Chambers S, Rahman A, Isenberg DA (2009) Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus 18:682–689CrossRefPubMed
18.
Zurück zum Zitat Bosch X, Guilabert A, Pallarés L, Cervera R, Ramos-Casals M, Bové A, Ingelmo M, Font J (2006) Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus 15:584–589CrossRefPubMed Bosch X, Guilabert A, Pallarés L, Cervera R, Ramos-Casals M, Bové A, Ingelmo M, Font J (2006) Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus 15:584–589CrossRefPubMed
19.
Zurück zum Zitat Danza A, Ruiz-Irastorza G (2013) Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies. Lupus 22:1286–1294CrossRefPubMed Danza A, Ruiz-Irastorza G (2013) Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies. Lupus 22:1286–1294CrossRefPubMed
20.
Zurück zum Zitat Tse KC, Tang CS, Lam MF, Yap DY, Chan TM (2009) Cost comparison between mycophenolate mofetil and cyclophosphamide-azathioprine in the treatment of lupus nephritis. J Rheumatol 36(1):76–81PubMed Tse KC, Tang CS, Lam MF, Yap DY, Chan TM (2009) Cost comparison between mycophenolate mofetil and cyclophosphamide-azathioprine in the treatment of lupus nephritis. J Rheumatol 36(1):76–81PubMed
21.
Zurück zum Zitat Ruiz-Irastorza G, Olivares N, Ruiz-Arruza I, Martinez-Berriotxoa A, Egurbide MV, Aguirre C (2009) Predictors of major infections in systemic lupus erythematosus. Arthritis Res Ther 11(4):R109CrossRefPubMedPubMedCentral Ruiz-Irastorza G, Olivares N, Ruiz-Arruza I, Martinez-Berriotxoa A, Egurbide MV, Aguirre C (2009) Predictors of major infections in systemic lupus erythematosus. Arthritis Res Ther 11(4):R109CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Navarro-Zarza J, Alvarez-Hernandez E, Casasola-Vargas J et al (2010) Prevalence of community-acquired and nosocomial infections in hospitalized patients with systemic lupus erythematosus. Lupus 19(1):43–48CrossRefPubMed Navarro-Zarza J, Alvarez-Hernandez E, Casasola-Vargas J et al (2010) Prevalence of community-acquired and nosocomial infections in hospitalized patients with systemic lupus erythematosus. Lupus 19(1):43–48CrossRefPubMed
23.
Zurück zum Zitat Tse KC, Tang CS, Lio WI, Lam MF, Chan TM (2006) Quality of life comparison between corticosteroid-and-mycofenolate mofetil and corticosteroid and oral cyclophosphamide in the treatment of severe lupus nephritis. Lupus 15(6):371–379CrossRefPubMed Tse KC, Tang CS, Lio WI, Lam MF, Chan TM (2006) Quality of life comparison between corticosteroid-and-mycofenolate mofetil and corticosteroid and oral cyclophosphamide in the treatment of severe lupus nephritis. Lupus 15(6):371–379CrossRefPubMed
Metadaten
Titel
Clinical characteristics and risk factors of infections in patients with systemic lupus erythematosus
verfasst von
Chengcheng Hou
Ou Jin
Xi Zhang
Publikationsdatum
09.07.2018
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 10/2018
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-018-4198-8

Weitere Artikel der Ausgabe 10/2018

Clinical Rheumatology 10/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.